Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II

Benjamin Stieglitz1, Christine Bee, Daniel Schwarz

  • 1Physikalische Chemie 1, Fakultät für Chemie und Biochemie, Ruhr-Universität Bochum, Bochum, Germany.

The EMBO Journal
|July 4, 2008
PubMed

Insights

Ras association domain family (RASSF) proteins are crucial for tumor suppression. Researchers elucidated the crystal structure of Ras bound to RASSF5 variants NORE1A/RAPL, revealing an extended interface that enhances complex stability.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Cancer Research

Background:

  • Ras association domain family (RASSF) proteins are key non-enzymatic adaptors involved in tumor suppression.
  • RASSF5, a member of this family, has two splice variants, NORE1A and RAPL, which mediate distinct cellular pathways.
  • These variants are activated by Ras and Rap signaling, respectively.

Purpose of the Study:

  • To determine the crystal structure of Ras in complex with the Ras binding domain (RBD) of NORE1A/RAPL.
  • To understand the structural basis for the interaction between Ras and NORE1A/RAPL.
  • To compare the binding characteristics of NORE1A/RAPL with other Ras effectors.

Main Methods:

  • X-ray crystallography to determine the structure of the Ras-RBD complex.
  • Structural analysis to identify key interaction interfaces.
  • Comparison of structural data with known Ras effector interactions.

Main Results:

  • The crystal structure of Ras bound to the NORE1A/RAPL RBD was determined.
  • NORE1A/RAPL RBD possesses unique structural elements that create an extended binding interface with Ras, including a novel Ras switch II binding site.
  • This enlarged interface leads to a significantly longer complex lifetime compared to enzymatic Ras effectors.

Conclusions:

  • The unique structural features of NORE1A/RAPL RBD explain their prolonged interaction with Ras.
  • This extended complex stability is a defining characteristic of NORE1A/RAPL as adaptors, differentiating them from transient enzymatic Ras effectors.
  • The findings provide insights into the distinct mechanisms of Ras signal transduction mediated by different effector families.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...